Minireviews
Copyright ©The Author(s) 2025.
World J Cardiol. Mar 26, 2025; 17(3): 103668
Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.103668
Table 1 Indications for fetal echocardiography
Indications for fetal echocardiography
Indicated
May be considered
Not indicated
Maternal factors (absolute risk)
Pre-gestational diabetesYes--
Gestational diabetes diagnosed in first or early second trimester-Yes-
Gestational diabetes diagnosed after second trimester--Yes
Phenylketonuria (phenylalanine level > 10 mg/dL)Yes--
Autoimmune disease: SSA/SSB positiveYes--
In vitro fertilization-Yes-
Confirmed fetal infection (TORCH- and parvovirus-B19-positive)Yes--
First- or second-degree relative with disease of Mendelian inheritance and history of childhood cardiac manifestationsYes--
Family history of CHD: First-degree relativeYes--
Family history of CHD: Second-degree or more distant relative--Yes
Obesity (BMI > 30 kg/m2)--Yes
RetinoidsYes--
ACE inhibitors-Yes-
Paroxetine-Yes-
Other selective serotonin reuptake inhibitors--Yes
Anticonvulsants--Yes
Alcohol--Yes
Lithium--Yes
Warfarin--Yes
Fetal factors identified during screening (absolute risk)
Suspected cardiac structural anomalyYes--
Fetal hydropsYes--
Extracardiac anomaly known to be associated with CHDYes--
Persistent fetal tachycardia (heart rate ≥ 180 bpm)Yes--
Suspected heart block or persistent fetal bradycardia (heart rate ≤ 110 bpm)Yes--
Frequent episodes or persistently irregular cardiac rhythmYes--
Suspected abnormality of cardiac function or cardiomegalyYes--
Chromosomal abnormalitiesYes--
Monochorionic twinningYes--
Nuchal translucency 3.0-3.4 mmYes-
Nuchal translucency ≥ 3.5 mmYes--
Single umbilical artery in isolation--Yes
Other considerations
Non-cardiac “soft marker” for aneuploidy--Yes
Abnormal serum analytes (e.g. α-fetoprotein level)--Yes
Echogenic intracardiac focus--Yes
Prenatal fever or viral infection with seroconversion only--Yes